A Non-Interventional Study to Document the Use of Straumann BLX Implants in Daily Dental Practice

A Non-Interventional Study to Document the Use of Straumann BLX Implants in Daily Dental Practice

Prospective, multi-center, non-interventional observation to document the success and survival rates of Straumann BLX Implants used for tooth replacement in cleared indications up to 1 year after implant placement

Objective of the study is to confirm the safety and performance of Straumann BLX Implants used for tooth replacement in cleared indications up to 12 months after implant placement. Implants used are Straumann® BLX Implant Roxolid® SLActive®. Regular Base (3.5 mm): implant diameters 3.75 and 4.5mm, in lengths 6, 8, 10, 12,14, 16 and 18 mm Wide Base (4.5 mm): diameter 5.5 mm in lengths 6, 8, 10 and 12 mm

Inclusion Criteria:

• Patients seeking an implant supported restoration
• all patients with conditions that are in accordance with the IFU
• Patients must provide their informed consent for study participation and must be willing and able to attend control visits
• Patients need to be at least 18 years old

Exclusion Criteria:

-